Ian E. Smith
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies 107
- Oncology top 0.05%
- HER2/EGFR in Cancer Research 69
- Cancer Treatment and Pharmacology 63
- Lung Cancer Research Studies 24
- Cancer Cells and Metastasis 21
- Pathology and Forensic Medicine top 0.2%
- Breast Lesions and Carcinomas 22
- Genetics top 0.2%
- Estrogen and related hormone effects 68
- Pulmonary and Respiratory Medicine top 0.2%
- Advanced Breast Cancer Therapies 24
- Co-authors
- Mitch DowsettJorge S. Reis‐FilhoWilliam D. FoulkesJohn M. ShneersonJanine SalterAnder UrruticoecheaGeraldine WalshRoger A’Hern
- Journals
- Journal of Clinical Oncology (42 papers)British Journal of Cancer (30 papers)Annals of Oncology (22 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Ian E. Smith
345 papers receiving 20.1k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Cancer Research 8.4k
- Oncology 11.1k
- Pathology and Forensic Medicine 2.5k
- Genetics 3.8k
- Pulmonary and Respiratory Medicine 4.4k
Countries citing papers authored by Ian E. Smith
This map shows the geographic impact of Ian E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian E. Smith more than expected).
Fields of papers citing papers by Ian E. Smith
This network shows the impact of papers produced by Ian E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian E. Smith. The network helps show where Ian E. Smith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian E. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 49 | |
| 4 | 2019 | 13 | |
| 5 | 2019 | 134 | |
| 6 | 2015 | 31 | |
| 7 | 2013 | 98 | |
| 8 | 2012 | 102 | |
| 9 | 2012 | 100 | |
| 10 | 2011 | 26 | |
| 11 | 2010 | 75 | |
| 12 | 2010 | 222 | |
| 13 | Integration of Signal Transduction Inhibitors with Endocrine Therapy | 2003 | 3 |
| 14 | 2003 | 71 | |
| 15 | A whole blood facscan assay to look at cytokine production by NK cells in cancer patients. | 1999 | 15 |
| 16 | 1995 | 7 | |
| 17 | 1985 | 14 | |
| 18 | Autologous bone marrow transplantation and solid tumors | 1984 | 4 |
| 19 | 1984 | 1 | |
| 20 | 1983 | 11 |
About Ian E. Smith
Ian E. Smith is a scholar working on Cancer Research, Oncology and Genetics, having authored 354 papers that have together received 20.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (107 papers), HER2/EGFR in Cancer Research (69 papers), Estrogen and related hormone effects (68 papers), Cancer Treatment and Pharmacology (63 papers), Advanced Breast Cancer Therapies (24 papers), Lung Cancer Research Studies (24 papers), Breast Lesions and Carcinomas (22 papers) and Cancer Cells and Metastasis (21 papers). The work is most often cited by research in Cancer Research (8.4k citations), Oncology (11.1k citations) and Pathology and Forensic Medicine (2.5k citations). Ian E. Smith has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Mitch Dowsett, Jorge S. Reis‐Filho, William D. Foulkes, John M. Shneerson, Janine Salter, Ander Urruticoechea, Geraldine Walsh, Roger A’Hern, Mary O’Brien and S. Ashley. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, The Breast and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.